中东和非洲细胞治疗市场预测至 2027 年 - COVID-19 影响和按治疗类型（同种异体、自体）进行的区域分析；产品（消耗品、设备、系统和软件）；技术（病毒载体技术、基因组编辑技术、体细胞技术、细胞永生化技术、细胞可塑性技术、三维技术）；应用（肿瘤学、心血管、骨科、伤口处理、其他应用）；最终用户（研究机构、医院等）和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

No. of Pages: 129    |    Report Code: TIPRE00019136    |    Category: Life Sciences

Explore in Your Language
English Arabic French German Italian Japanese Korean Spanish
Middle East and Africa Cell Therapy Market
Free Sample Buy Now

市场介绍

细胞疗法是将活的完整细胞注射、植入或移植到患者体内的过程。这项技术依赖于用健康的功能细胞替代功能失调的细胞。主要用于此类先进疗法的细胞是干细胞，因为它们能够分化成修复受损或有缺陷的组织或细胞所需的特定细胞。此外，细胞疗法在再生医学的开发中也有应用。

市场动态

中东和非洲细胞治疗市场预计将从 2019 年的 2.344 亿美元增至 2027 年的 3.467 亿美元；预计 2019 年至 2027 年复合年增长率为 5.1%。慢性病患病率不断上升、再生药物的采用不断增加以及细胞疗法的批准数量不断增加等因素预计将在未来几年推动细胞疗法市场的增长。然而，在预测期内，市场可能会受到细胞疗法制造成本高等风险因素的影响。

COVID-19 大流行已成为中东和非洲最重大的挑战地区。阿联酋和沙特阿拉伯等国也登记了大量阳性患者。因此，各国的要求面临着一些挑战。各国的封锁初期影响了这些地区许多仪器的供应。因此，许多组织正在与其他组织合作，通过使用细胞疗法治疗 COVID 19 来克服这一流行病。例如，总部位于阿拉伯联合酋长国的阿布扎比干细胞中心 (ADSCC) 已与 Pluristem Therapeutics Inc. 签订合作协议，开发治疗COVID-19的细胞疗法和再生药物。

市场范围

中东范围非洲细胞治疗市场包括治疗类型、产品、技术、应用、最终用户和国家。从治疗类型来看，同种异体细分市场在2019年中东和非洲细胞治疗市场中占据最大份额。 从产品来看，耗材细分市场在2019年中东和非洲细胞治疗市场中占据最大份额2019年，按技术划分，病毒载体技术领域在中东和非洲细胞治疗市场中占据最大份额。在应用方面，肿瘤学领域在2019年中东和非洲细胞治疗市场中占据最大份额。 2019年。就最终用户而言，研究机构细分市场在2019年中东和非洲细胞治疗市场中占据最大份额。

主要来源和上市公司

与中东和非洲细胞治疗市场报告相关的几个主要主要和次要来源是世界卫生组织 (WHO)、疾病控制与预防 (CDC)、南非国家卫生研究院、阿布扎比卫生部、阿布扎比干细胞中心 (ADSCC) 等等。

购买原因报告

< ul>
  • 它提供了对中东和非洲、细胞治疗市场格局的了解，并确定了最有可能保证强劲回报的细胞治疗细分市场。
  • < span>它通过了解中东和非洲细胞治疗市场不断变化的竞争格局，指导您在竞争中保持领先地位。
  • 它有助于有效规划并购，以及合作伙伴关系通过确定最有希望销售的细分市场来涉足细胞治疗市场。
  • 它通过对中东和非洲细胞治疗市场各个细分市场的细胞治疗市场表现进行敏锐和全面的分析，促进明智的业务决策。< /li>
  • 它提供了2019年至2027年期间基于各个细分市场的细胞治疗市场收入预测。

    • MIDDLE东部和非洲细胞治疗市场细分

    按治疗类型

    • 异体
    • 自体

    按产品

    • 消耗品
    • 设备
    • 系统和软件

    按技术

    • 病毒载体技术
    • 基因组编辑技术
    • 体细胞技术< /li>
    • 细胞永生化技术
    • 细胞可塑性技术
    • 三维技术

    按应用

    The List of Companies - Middle East and Africa Cell Therapy Market

    1. NuVasive, Inc.
    2. Smith & Nephew
    3. Bristol-Myers Squibb Company
    Frequently Asked Questions
    How big is the Middle East and Africa Cell Therapy Market?

    The Middle East and Africa Cell Therapy Market is valued at US$ 234.4 Million in 2019, it is projected to reach US$ 346.7 Million by 2027.

    What is the CAGR for Middle East and Africa Cell Therapy Market by (2019 - 2027)?

    As per our report Middle East and Africa Cell Therapy Market, the market size is valued at US$ 234.4 Million in 2019, projecting it to reach US$ 346.7 Million by 2027. This translates to a CAGR of approximately 5.1% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Cell Therapy Market report typically cover these key segments-

  • 治疗类型 (同种异体, 自体)
  • 产品 (耗材, 设备, 系统和软件)
  • 技术 (病毒载体技术, 基因组编辑技术, 体细胞技术, 细胞永生化技术, 细胞可塑性技术, 三维技术)

    • What is the historic period, base year, and forecast period taken for Middle East and Africa Cell Therapy Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Cell Therapy Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
    • Who are the major players in Middle East and Africa Cell Therapy Market?

    The Middle East and Africa Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • NuVasive, Inc.
  • Smith & Nephew
  • Bristol-Myers Squibb Company
    • Who should buy this report?

    The Middle East and Africa Cell Therapy Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Request Free Sample Buy Now
    middle-east-and-africa-cell-therapy-market